Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
First in Human Study With NG-641, a Tumour Selective Transgene Expressing Adenoviral Vector
- Status
- COMPLETED
- Phase
- PHASE1
QUILT-3.064: PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers
- Status
- COMPLETED
- Phase
- PHASE1
ImmunoPET With an Anti-CD8 Imaging Agent
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy of Point Of Service Testing in MBC
- Status
- UNKNOWN
- Phase
- NA
A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Exercise Therapy in Radiation Therapy
- Status
- COMPLETED
- Phase
- NA
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment
- Status
- UNKNOWN
- Phase
- N/A
Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.
- Status
- TERMINATED
- Phase
- PHASE2
Autoantibodies in Treatment with Immune Checkpoint Inhibitors (AUTENTIC)
- Status
- COMPLETED
- Phase
- N/A
An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced " Cold " Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
The Lyon Real World Evidence in Metastatic NeuroEndocrine Tumours
- Status
- UNKNOWN
- Phase
- N/A
First in Human Study of NG-350A (an Oncolytic Adenoviral Vector Which Expresses an Anti-CD40 Antibody)
- Status
- COMPLETED
- Phase
- PHASE1
Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention
- Status
- COMPLETED
- Phase
- NA